Company Enters Femto-Cataract Arena

Expanding its vision care business into the femtosecond laser-assisted cataract surgery market, Abbott completed its acquisition of OptiMedica Corporation, developer of the Catalys Precision Laser System. The image-guided Catalys has both CE Mark in Europe and FDA clearance in the United States.

Abbott also announced that it received FDA approval for the Healon Duet Dual Pack ophthalmic viscosurgical device, which includes Healon and Healon EndoCoat. In addition, the company received FDA approval for the Tecnis Toric 1-Piece intraocular lens for the treatment of cataract and pre-existing corneal astigmatism.